Early Experiences with Nivolumab in Patients with Metastatic Renal Cell Carcinoma and Failed Target Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early Experiences with Nivolumab in Patients with Metastatic Renal Cell Carcinoma and Failed Target Therapy

Published:2019-08-31 Issue:2 Volume:17 Page:96-102
ISSN:2234-4977
Container-title:The Korean Journal of Urological Oncology
language:en
Short-container-title:Korean J Urol Oncol

Author:

Lee Jong Hoon,Kang Minyong,Chung Jae Hoon,Sung Hyun Hwan,Jeon Hwang Gyun,Jeong Byung Chang,Jeon Seong Soo,Lee Hyun Moo,Park Se Hoon,Kim Binnari,Kwon Ghee Young,Seo Seong Il^ORCID

Funder

National Research Foundation of Korea

Ministry of Science and ICT

Korea Health Industry Development Institute

Ministry of Health and Welfare

Publisher

Korean Urological Oncology Society

Link

http://kjuo.or.kr/upload/pdf/kjuo-17-2-96.pdf

Reference22 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Current and future systemic treatments for renal cell carcinoma

3. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

5. Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP